Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT.
Journal: Current oncology (Toronto, Ont.)
Published: January 06, 2026
LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models.
Journal: Blood cancer discovery
Published: November 18, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 18, 2025
Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis.
Journal: British journal of haematology
Published: August 28, 2025
Clinical decisions in clonal hematopoiesis: a contemporary review for clinicians.
Journal: Haematologica
Published: August 27, 2025
Novel and emerging therapeutic strategies for clonal hematopoiesis.
Journal: Haematologica
Published: July 11, 2025
Blood-based epigenetic instability linked to human aging and disease.
Journal: Nature communications
Published: June 18, 2025
Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial.
Journal: The Lancet. Haematology
Published: May 23, 2025
Mutant IDH1 cooperates with NPM1c or FLT3ITD to drive distinct myeloid diseases and molecular outcomes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 16, 2025
Last Updated: 09/26/2026